![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Acute Erythroid Leukemia - 189 Studies Found
Recruiting |
: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy :
|
Active, not recruiting |
: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
Terminated |
: Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
Terminated |
: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia :
|
Active, not recruiting |
: Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
Active, not recruiting |
: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay :
|
Active, not recruiting |
: Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML :
|
Active, not recruiting |
: Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia :
: |
Withdrawn |
: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia :
|
Completed |
: Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes :
|